The clinical outcomes and effectiveness of antiviral agents among underweight patients with COVID-19.

Jheng-Yen WuMei-Yuan LiuMei-Chuan LeeKuo-Chuan HungWan-Hsuan HsuYa-Wen TsaiTing-Hui LiuPo-Yu HuangMin-Hsiang ChuangShu-Ching TsengChih-Ying LuChih-Cheng Lai

Published in: Expert review of anti-infective therapy (2024)

Underweight status may be associated with a higher risk of all-cause hospitalization and death in patients with COVID-19.Among underweight patients, antiviral agents demonstrated clinically beneficial effects.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
randomized controlled trial
chronic kidney disease
systematic review
peritoneal dialysis